The Oncosearch | Oncotarget

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Research Paper

Caitlin D. Lowery, Wayne Blosser, Michele Dowless, Matthew Renschler, Lisa V. Perez, Jennifer Stephens, Bronislaw Pytowski, Heather Wasserstrom, Louis F. Stancato, Beverly Falcon

Published Sep 17, 2019 · Vol. 10, No. 53 · pp. 5523-5533

Keywords: angiogenesis, pediatric cancer, VEGFR2, ramucirumab, DC101

Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma Correction

Tiansuo Zhao, He Ren, Li Jia, Jing Chen, Wen Xin, Fan Yan, Jing Li, Xiuchao Wang, Song Gao, Dong Qian, Chongbiao Huang, Jihui Hao

Published Sep 9, 2019 · Vol. 10, No. 53 · pp. 5569-5570

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting Research Paper

Alvin Y. Liu, Adelle D. Kanan, Tomasz P. Radon, Siama Shah, Mark E. Weeks, Julie M. Foster, Jane K. Sosabowski, Laurent Dumartin, Tatjana Crnogorac-Jurcevic

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4276-4289

Keywords: pancreatic cancer, eAGR2, chimeric antibody, prostate cancer, tumor localization

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile Research Paper

Shuhei Suzuki, Masahiro Yamamoto, Keita Togashi, Tomomi Sanomachi, Asuka Sugai, Shizuka Seino, Takashi Yoshioka, Chifumi Kitanaka, Masashi Okada

Published May 28, 2019 · Vol. 10, No. 37 · pp. 3547-3558

Keywords: brexpiprazole, serotonin-dopamine activity modulator, drug repositioning, drug repurposing, survivin

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer Editorial

Snigdha Banerjee, Arnab Ghosh, Daniel D. VonHoff, Sushanta K. Banerjee

Published May 20, 2019 · Vol. 10, No. 38 · pp. 3579-3580

Keywords: Cyr61, gemcitabine, pancreatic cancer, chemoresistance

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model Research Paper

Tatsuzo Mizukami, Hirofumi Kamachi, Yuki Fujii, Fumihiko Matsuzawa, Takahiro Einama, Futoshi Kawamata, Nozomi Kobayashi, Yutaka Hatanaka, Akinobu Taketomi

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33844-33852

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Barbara Vizio, Monica Boita, Carmen Cristiano, Jasenka Mazibrada, Ornella Bosco, Anna Novarino, Adriana Prati, Savino Sciascia, Giovanni Rolla, Libero Ciuffreda, Giuseppe Montrucchio, Graziella Bellone

Published Aug 28, 2018 · Vol. 9, No. 67 · pp. 32795-32809

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Nicolas Williet, Thomas Di Bernardo, ChloÃ© Vernet, LÃ©a Saban Roche, Thierry Muron, Xavier Roblin, Nicolas Magne, Jean-Marc Phelip

Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 31999-32009

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Gemma Bruera, Silvia Massacese, Stefania Candria, Antonio Galvano, Rosa Manetta, Aldo Victor Giordano, Sergio Carducci, Alessandra Di Sibio, Eugenio Ciacco, Antonio Russo, Enrico Ricevuto, on behalf of Oncology Network ASL1 Abruz, Italy

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31861-31876

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma Research Paper

MarÃa InÃ©s Molejon, Mirna Swayden, Daniele Fanale, Jennifer Bintz, Odile Gayet, Philippe Soubeyran, Juan Iovanna

Published Jul 20, 2018 · Vol. 9, No. 56 · pp. 30837-30846

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells Research Paper

Yukiko Miyatake, Yusuke Ohta, Shunji Ikeshita, Masanori Kasahara

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 29845-29856

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis Meta-Analysis

Chiara Citterio, Michela Baccini, Elena Orlandi, Camilla Di Nunzio, Luigi Cavanna

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29801-29809

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Research Paper

Shuhei Shinoda, Seiji Kaino, Shogo Amano, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28434-28444

The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma Research Paper

Carole Vitellius, Lionel Fizanne, Elodie Menager-Tabourel, Joelle Nader, Nathalie Baize, Margot Laly, Emilie Lermite, Sandrine Bertrais, FX Caroli-Bosc

Published Jun 15, 2018 · Vol. 9, No. 46 · pp. 28069-28082

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma Research Paper

Anne Aarnink, Corentin Richard, Caroline Truntzer, Julie Vincent, Leila Bengrine, AngÃ©lique Vienot, Christophe Borg, Francois Ghiringhelli

Published May 22, 2018 · Vol. 9, No. 39 · pp. 25617-25629

Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac Research Paper

Yoko Goto, Ryo Ashida, Akira Nakamura, Satoshi Itasaka, Keiko Shibuya, Mami Akimoto, Nobutaka Mukumoto, Shigemi Matsumoto, Masashi Kanai, Hiroyoshi Isoda, Toshihiko Masui, Yuzo Kodama, Mitsuhiro Nakamura, Kyoichi Takaori, Takashi Mizowaki, Masahiro Hiraoka

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23628-23635

Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase Research Paper

Cheng-Han Yu, Chi-Chi Chou, Hsin-Fang Tu, Wei-Chieh Huang, Ya-Yeh Ho, Kay-Hooi Khoo, Ming-Shyue Lee, Geen-Dong Chang

Published Apr 20, 2018 · Vol. 9, No. 30 · pp. 21512-21529

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Research Paper

Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma Correction

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting Research Paper

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile Research Paper

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer Editorial

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model Research Paper

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma Research Paper

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells Research Paper

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis Meta-Analysis

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Research Paper

The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma Research Paper

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma Research Paper

Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac Research Paper

Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase Research Paper

Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review Review

Anti-cachectic effect of Antrodia cinnamomea extract in lung tumor-bearing mice under chemotherapy Research Paper

Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years Meta-Analysis

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Research Paper

Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma Correction

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting Research Paper

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile Research Paper

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer Editorial

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model Research Paper

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma Research Paper

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells Research Paper

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis Meta-Analysis

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Research Paper

The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma Research Paper

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma Research Paper

Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac Research Paper

Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase Research Paper

Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review Review

Anti-cachectic effect of Antrodia cinnamomea extract in lung tumor-bearing mice under chemotherapy Research Paper

Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years Meta-Analysis